<DOC>
	<DOCNO>NCT00837811</DOCNO>
	<brief_summary>To evaluate safety tolerability LY2127399 administer subcutaneous injection 48 week patient Rheumatoid Arthritis</brief_summary>
	<brief_title>An Open Label Extension Study Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Have give write informed consent Women must pregnant , breastfeed risk become pregnant study participation Have participate either Study BCDG Study BCDH Have , Study BCDG Study BCDH , safety event , ( include recent , ongoing , serious infection , serious drug reaction , AE cause discontinuation treatment ) opinion investigator pose unacceptable risk participation study . Have receive , Study BCDG Study BCDH , drug allow study protocol include unapproved drug , biologic DMARDs , live vaccine . Enrollment clinical trial involve offlabel use investigational drug device , enrollment type medical research .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Arthritis</keyword>
</DOC>